GLP-1 prescriptions for weight loss are shooting up, despite obstacles

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a new Fair Health report.
The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a new Fair Health report.
Tom Cowhey served as finance chief at CVS before the healthcare giant named a new CFO in April.
Young adults could struggle to navigate government bureaucracy and face other challenges managing work requirements or increased eligibility checks in the safety-net insurance program, the Urban Institute found.
The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F. Kennedy Jr. is removing guidance that healthy children and pregnant women receive COVID shots.
Federal agencies are seeking public feedback on how to improve price transparency around prescription drugs and boost hospital compliance and enforcement.
A bankruptcy judge on Wednesday approved Rite Aid’s pharmacy asset sales to a variety of buyers. Purchase prices were not disclosed.
The digital musculoskeletal care company opened at $39.25 per share Thursday, rising 23% above its public offering price.
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for Evernorth’s employer and health plan clients.
Nonprofits have struggled to recover since the COVID-19 pandemic. Now, providers are grappling once more with turbulent macroeconomic conditions.
Speaker Mike Johnson negotiated a number of last minute changes to the megabill to get it across the finish line, including moving up the start date for Medicaid work requirements. The House passed the bill 215-214 on Thursday morning.